# | Website | Score in June 2020 | 1m changes |
---|
1 | Alzheimer’s disease | 64 | 0 |
2 | 10.1353/smx.2007.0045 | 63 | 0 |
3 | Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for t... | 52 | 0 |
4 | A Systematic Literature Review of Twitter Research from a Socio-Political Revolution Perspective | 40 | 0 |
5 | Indoor air pollution: a public health perspective | 33 | 0 |
6 | History of Ancient Copper Smelting Pollution During Roman and Medieval Times Recorded in Greenland Ice | 33 | 0 |
7 | Alzheimer’s disease | 32 | 0 |
8 | Parkinson’s Disease: Genetics and Pathogenesis | 25 | 0 |
9 | Prevention and treatment of the common cold: making sense of the evidence | 21 | 0 |
10 | Cholera | 15 | 0 |
11 | Does This Patient Have Influenza? | 15 | 0 |
12 | Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy | 15 | 0 |
13 | Acute Diarrhea in Children | 12 | 0 |
14 | Cancer is a Preventable Disease that Requires Major Lifestyle Changes | 8 | 0 |
15 | American Cancer Society guidelines on nutrition and physical activity for cancer prevention | 8 | 0 |
16 | 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 | 8 | 0 |
17 | Screening for breast cancer with mammography | 8 | 0 |
18 | Nonmelanoma Skin Cancer | 8 | 0 |
19 | Epidemiology and Economic Burden of Nonmelanoma Skin Cancer | 8 | 0 |
20 | Global cancer statistics | 8 | 0 |
21 | Understanding the symptoms of the common cold and influenza | 8 | 0 |
22 | Alzheimer’s Disease | 8 | 0 |
23 | Survival in dementia and predictors of mortality: a review | 8 | 0 |
24 | Exercise programs for people with dementia | 8 | 0 |
25 | The global implications of diabetes and cancer | 7 | 0 |
26 | Transmission of influenza A in human beings | 7 | 0 |
27 | Physical interventions to interrupt or reduce the spread of respiratory viruses | 7 | 0 |
28 | The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews | 7 | 0 |
29 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Stud... | 4 | 0 |
30 | The common cold | 4 | 0 |
31 | Non-steroidal anti-inflammatory drugs for the common cold | 4 | 0 |
32 | Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the... | 4 | 0 |
33 | Hyperglycemic Crises in Adult Patients With Diabetes | 3 | 0 |
34 | The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation | 3 | 0 |
35 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease St... | 3 | 0 |
36 | Economic Costs of Diabetes in the U.S. in 2012 | 3 | 0 |
37 | What is Type 1 Diabetes? | 3 | 0 |
38 | Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials | 3 | 0 |
39 | Acute Fever and Petechial Rash Associated with Influenza A Virus Infection | 3 | 0 |
40 | Influenza in children | 3 | 0 |
41 | GASTRIC ’FLU INFLUENZA B CAUSING ABDOMINAL SYMPTOMS IN CHILDREN | 3 | 0 |
42 | Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection | 3 | 0 |
43 | Clinical Signs and Symptoms Predicting Influenza Infection | 3 | 0 |
44 | Cost-effectiveness of newer treatment strategies for influenza | 3 | 0 |
45 | CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA | 2 | 0 |
46 | Malaria: | 1 | 0 |
47 | Is malaria a disease of poverty? A review of the literature | 1 | 0 |
48 | Malaria | 1 | 0 |
49 | Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries | 0 | 0 |
50 | Response to Malaria Epidemics in Africa | 0 | 0 |
51 | Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria | 0 | 0 |
52 | Laboratory diagnosis of malaria in nonhuman primates | 0 | 0 |
53 | Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination | 0 | 0 |
54 | Spread of Artemisinin Resistance in Plasmodium falciparum Malaria | 0 | 0 |
55 | Anopheles gambiaeGenome: Completing the Malaria Triad | 0 | 0 |
56 | Malaria zoonoses | 0 | 0 |
57 | Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria | 0 | 0 |
58 | Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence | 0 | 0 |
59 | Redefining cerebral malaria by including malaria retinopathy | 0 | 0 |
60 | The therapeutic potential of metal-based antimalarial agents: Implications for the mechanism of action | 0 | 0 |
61 | Malaria Primer for Clinicians in the United States | 0 | 0 |
62 | History of malaria research and its contribution to the malaria control success in Suriname: a review | 0 | 0 |
63 | Substandard medicines in resource-poor settings: a problem that can no longer be ignored | 0 | 0 |
64 | Plasmodium knowlesi:Finally Being Recognized | 0 | 0 |
65 | Plasmodium knowlesi: A Malaria Parasite of Monkeys and Humans | 0 | 0 |
66 | The cellular and molecular basis for malaria parasite invasion of the human red blood cell | 0 | 0 |
67 | History of Human Parasitology | 0 | 0 |
68 | Advances and challenges in malaria vaccine development | 0 | 0 |
69 | Malaria in the Greater Mekong Subregion: Heterogeneity and complexity | 0 | 0 |
70 | Artemisinin resistance: current status and scenarios for containment | 0 | 0 |
71 | Thiamin (Vitamin B1) Biosynthesis and Regulation: A Rich Source of Antimicrobial Drug Targets? | 0 | 0 |
72 | Electronic mosquito repellents for preventing mosquito bites and malaria infection | 0 | 0 |
73 | Malaria Management: Past, Present, and Future | 0 | 0 |
74 | Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications | 0 | 0 |
75 | Shrinking the malaria map: progress and prospects | 0 | 0 |
76 | The ’hidden’ burden of malaria: cognitive impairment following infection | 0 | 0 |
77 | Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs | 0 | 0 |
78 | Malaria Prevention in Short-Term Travelers | 0 | 0 |
79 | A new world malaria map: Plasmodium falciparum endemicity in 2010 | 0 | 0 |
80 | Vaccines for preventing malaria (SPf66) | 0 | 0 |
81 | Malaria in 2002 | 0 | 0 |
82 | Spurious and counterfeit drugs: a growing industry in the developing world | 0 | 0 |
83 | European Vaccine Initiative: lessons from developing malaria vaccines | 0 | 0 |
84 | Vaccines for preventing malaria (blood-stage) | 0 | 0 |
85 | Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project | 0 | 0 |
86 | The Changing Disease-Scape in the Third Epidemiological Transition | 0 | 0 |
87 | The impact of maternal malaria on newborns | 0 | 0 |
88 | Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 | 0 | 0 |
89 | Population genetics of malaria resistance in humans | 0 | 0 |
90 | Vaccines against malaria | 0 | 0 |
91 | Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria | 0 | 0 |
92 | Technologies for global health | 0 | 0 |
93 | Reflections on the ’discovery’ of the antimalarial qinghao | 0 | 0 |
94 | Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome | 0 | 0 |
95 | Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite | 0 | 0 |
96 | Drugs for preventing malaria in travellers | 0 | 0 |
97 | Malaria, Plasmodium falciparum and its apicoplast | 0 | 0 |
98 | Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women | 0 | 0 |
99 | The Quest for Quinine: Those Who Won the Battles and Those Who Won the War | 0 | 0 |
100 | Dihydroartemisinin/Piperaquine | 0 | 0 |
101 | Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa? | 0 | 0 |
102 | Ongoing challenges in the management of malaria | 0 | 0 |
103 | Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa | 0 | 0 |
104 | How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria | 0 | 0 |
105 | Discoverers of quinine | 0 | 0 |
106 | Malaria in adolescence: burden of disease, consequences, and opportunities for intervention | 0 | 0 |
107 | Global malaria mortality between 1980 and 2010: a systematic analysis | 0 | 0 |
108 | Ecology and conservation biology of avian malaria | 0 | 0 |
109 | Insecticide-treated bed nets and curtains for preventing malaria | 0 | 0 |
110 | Counterfeit and substandard antimalarial drugs in Cambodia | 0 | 0 |
111 | The use of remotely sensed environmental data in the study of malaria | 0 | 0 |
112 | A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy | 0 | 0 |
113 | Molecular interactions in the placenta during malaria infection | 0 | 0 |
114 | Intermittent preventive treatment for malaria in children living in areas with seasonal transmission | 0 | 0 |
115 | Antipyretic measures for treating fever in malaria | 0 | 0 |
116 | Estimating the Number of Insecticide-Treated Nets Required by African Households to Reach Continent-wide Malaria Coverage Targets | 0 | 0 |
117 | Transgenic RodentPlasmodium bergheiParasites as Tools for Assessment of Functional Immunogenicity and Optimization of Human Malaria Vaccines | 0 | 0 |
118 | Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasites | 0 | 0 |
119 | Vitamin B metabolism in Plasmodium falciparum as a source of drug targets | 0 | 0 |
120 | Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa | 0 | 0 |
121 | Counterfeit anti-infective drugs | 0 | 0 |
122 | A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia | 0 | 0 |
123 | Insecticide-treated net coverage in Africa: mapping progress in 2000–07 | 0 | 0 |
124 | Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum | 0 | 0 |
125 | Management of Severe Malaria: Results from Recent Trials | 0 | 0 |
126 | Transfusion‐Transmitted Malaria in Countries Where Malaria Is Endemic: A Review of the Literature from Sub‐Saharan Africa | 0 | 0 |
127 | WHO combats counterfeit malaria drugs in Asia | 0 | 0 |
128 | MOSQUITO BEHAVIOR AND VECTOR CONTROL | 0 | 0 |
129 | Working without a blindfold: the critical role of diagnostics in malaria control | 0 | 0 |
130 | Indoor residual spraying for preventing malaria | 0 | 0 |
131 | A Fresh Look at the Origin of Plasmodium falciparum, the Most Malignant Malaria Agent | 0 | 0 |
132 | Malaria vector control: from past to future | 0 | 0 |
133 | Cerebral malaria | 0 | 0 |
134 | SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY | 0 | 0 |
135 | What is the evidence for the existence of Plasmodium ovale hypnozoites? | 0 | 0 |
136 | Malaria in pregnancy in the Asia-Pacific region | 0 | 0 |
137 | Immune mechanisms in malaria: new insights in vaccine development | 0 | 0 |
138 | Ferrocene-based antimalarials | 0 | 0 |
139 | Costs and financial feasibility of malaria elimination | 0 | 0 |
140 | The economic and social burden of malaria | 0 | 0 |
141 | Malaria and Rome | 0 | 0 |
142 | Critical Care Aspects of Malaria | 0 | 0 |
143 | Artesunate versus quinine for treating severe malaria | 0 | 0 |
144 | Challenges of drug-resistant malaria | 0 | 0 |
145 | Respiratory Manifestations of Malaria | 0 | 0 |
146 | The Plasmodium falciparum-infected red blood cell | 0 | 0 |
147 | Clinical review: Severe malaria | 0 | 0 |
148 | Systems immunology of human malaria | 0 | 0 |
149 | Drug Resistance in Plasmodium: Natural Products in the Fight Against Malaria | 0 | 0 |
150 | Mosquito larval source management for controlling malaria | 0 | 0 |
151 | Global Status of DDT and Its Alternatives for Use in Vector Control to Prevent Disease | 0 | 0 |
152 | Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond | 0 | 0 |
153 | Malaria Parasite Pre-Erythrocytic Stage Infection: Gliding and Hiding | 0 | 0 |
154 | The Forgotten Malaria | 0 | 0 |
155 | Genetic variation and susceptibility to infection: the red cell and malaria | 0 | 0 |
156 | Qinghaosu (Artemisinin): The Price of Success | 0 | 0 |
157 | Determinants of relapse periodicity in Plasmodium vivax malaria | 0 | 0 |
158 | Malaria Eradication in the United States | 0 | 0 |
159 | Malaria Rapid Diagnostic Tests | 0 | 0 |
160 | Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border | 0 | 0 |
161 | Malaria control in Bhutan: case study of a country embarking on elimination | 0 | 0 |